Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 28, 2023; 29(44): 5919-5934
Published online Nov 28, 2023. doi: 10.3748/wjg.v29.i44.5919
Published online Nov 28, 2023. doi: 10.3748/wjg.v29.i44.5919
Figure 6 In vivo confirmation of the role of Tousled-like kinase 1 in gastric cancer progression.
A and B: Relative tumorigenesis between the control and Tousled-like kinase 1 (TLK1) overexpression groups; C and D: Differences in tumor volume and mass between the control and TLK1 overexpression groups; E: Western blot verifying differential TLK1 expression in tumor tissues; F and G: Immunohistochemical (IHC) staining detecting the differences in tumor growth factor-beta expression between the control and TLK1 overexpression groups; H and I: IHC staining showing the differences in Ki-67 expression between the control and TLK1 overexpression groups; J and K: IHC and HE staining disclosing the differences in apoptosis between the control and TLK1 overexpression groups. aP < 0.05. TGF-beta: Tumor growth factor-beta; NC: Negative control; OE: Overexpression.
- Citation: Sun RC, Li J, Li YX, Wang HZ, Dal E, Wang ML, Li YX. Tousled-like kinase 1 promotes gastric cancer progression by regulating the tumor growth factor-beta signaling pathway. World J Gastroenterol 2023; 29(44): 5919-5934
- URL: https://www.wjgnet.com/1007-9327/full/v29/i44/5919.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i44.5919